Ketone bodies and their potential as biomarkers in relapsed/refractory diffuse large B-cell lymphoma
New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. While most patients respond favorably to initial treatment, a significant percentage develop relapsed or refractory (R/R) disease, which limits therapeutic options and worsens prognosis. A recent study published in the journal Cancers has identified two […]
